Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (9): 1076-1080.doi: 10.12092/j.issn.1009-2501.2024.09.015

Previous Articles    

Development of pharmacogenomics education in China and the United States

WANG Quanlin1, SUN Shusen2, ZHANG Wei1, CAO Dan3, JIN Yisu3   

  1. 1 Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, Hu nan, China; 2 Western New England University, Springfild 01119, Massachusetts, United States; 3 Center for Teaching and Learning Development, Central South University, Changsha 410000, Hunan, China
  • Received:2023-11-09 Revised:2024-02-21 Online:2024-09-26 Published:2024-08-21

Abstract:

Pharmacogenomics (PGx) is a science based on functional genomics and molecular pharmacology, which has been rapidly developed and gradually applied to clinical practice in recent years. Therefore, China and the United States are committed to promoting the development of PGx education. This paper reviews PGx education in China and the United States, clarifies the significance of developing PGx education, and provides a detailed introduction to the current development status and challenges of PGx education in universities and clinical settings. Additionally, this paper makes some recommendations for developing PGx education and discusses future development trends in both countries.

Key words: pharmacogenomics, course offering, professional training, clinical practice, teaching design

CLC Number: